Holen Sie sich die Stockscreener-App
15.20
7.34%
1.04
Handel nachbörslich:
15.00
-0.20
-1.32%
Schlusskurs vom Vortag:
$14.16
Offen:
$13.99
24-Stunden-Volumen:
1.32M
Relative Volume:
1.11
Marktkapitalisierung:
$765.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-156.39M
KGV:
-4.1192
EPS:
-3.69
Netto-Cashflow:
$-123.06M
1W Leistung:
+12.51%
1M Leistung:
+14.20%
6M Leistung:
+34.87%
1J Leistung:
+17.65%
1-Tages-Spanne:
$13.72
$15.30
1-Wochen-Bereich:
$13.23
$15.30
52-Wochen-Spanne:
$7.30
$16.32
Kalvista Pharmaceuticals Inc Stock (KALV) Company Profile
Firmenname
Kalvista Pharmaceuticals Inc
Sektor
Branche
Telefon
(857) 999-0075
Adresse
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Vergleichen Sie KALV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KALV
Kalvista Pharmaceuticals Inc
|
15.20 | 719.36M | 0 | -156.39M | -123.06M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Kalvista Pharmaceuticals Inc Stock (KALV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-31 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-12-18 | Eingeleitet | BofA Securities | Buy |
| 2020-06-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-07-29 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-20 | Eingeleitet | Needham | Buy |
| 2018-10-30 | Eingeleitet | Jefferies | Buy |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-08-31 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Kalvista Pharmaceuticals Inc Aktie (KALV) Neueste Nachrichten
Short interest data insights for KalVista Pharmaceuticals Inc.Layoff News & Smart Allocation Stock Reports - Newser
Combining machine learning predictions for KalVista Pharmaceuticals Inc.2025 Fundamental Recap & Weekly High Momentum Picks - Newser
What is KalVista Pharmaceuticals Inc. s debt to equity ratioDip Buying & Safe Entry Point Identification - khodrobank.com
What MACD and RSI say about KalVista Pharmaceuticals Inc.2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Price action breakdown for KalVista Pharmaceuticals Inc.Jobs Report & Verified Momentum Stock Ideas - Newser
Is KalVista Pharmaceuticals Inc. building a consolidation baseQuarterly Profit Report & Fast Entry Momentum Trade Alerts - Newser
Can technical indicators confirm KalVista Pharmaceuticals Inc.’s reversalDollar Strength & High Yield Equity Trading Tips - Newser
How high can KalVista Pharmaceuticals Inc. stock goMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser
Price momentum metrics for KalVista Pharmaceuticals Inc. explainedSwing Trade & Weekly Top Performers Watchlists - Newser
Chart based exit strategy for KalVista Pharmaceuticals Inc.2025 Top Decliners & AI Driven Stock Reports - Newser
How institutional ownership impacts KalVista Pharmaceuticals Inc. stock2025 Top Gainers & Consistent Profit Alerts - Newser
Is KalVista Pharmaceuticals Inc. stock a smart retirement pickEarnings Miss & Weekly High Potential Stock Alerts - khodrobank.com
KALVISTA PHARMACEUTICALS Earnings Preview: Recent $KALV Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Can volume confirm reversal in KalVista Pharmaceuticals Inc.2025 Analyst Calls & Entry Point Strategy Guides - Newser
KalVista Pharmaceuticals Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - kangso.co.kr
Analyzing recovery setups for KalVista Pharmaceuticals Inc. investorsTrade Volume Report & Technical Entry and Exit Tips - Newser
Real time social sentiment graph for AFRIWJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Sentiment analysis tools applied to KalVista Pharmaceuticals Inc.July 2025 Volume & Fast Gaining Stock Reports - Newser
How to build a dashboard for KalVista Pharmaceuticals Inc. stockWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
KalVista Pharmaceuticals Inc. stock volume spike explainedQuarterly Portfolio Report & Accurate Buy Signal Alerts - Newser
KalVista Pharmaceuticals Inc. stock trend outlook and recovery path2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
KalVista Pharmaceuticals Inc. Stock Fails to Break Resistance Traders React getLinesFromResByArray error: size == 0 - kangso.co.kr
Real time social sentiment graph for KalVista Pharmaceuticals Inc.Portfolio Growth Summary & High Accuracy Trade Alerts - Newser
Is KalVista Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Finanzdaten der Kalvista Pharmaceuticals Inc-Aktie (KALV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kalvista Pharmaceuticals Inc-Aktie (KALV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yea Christopher | CHIEF DEVELOPMENT OFFICER |
Aug 25 '25 |
Sale |
13.42 |
1,954 |
26,223 |
132,052 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER |
Aug 25 '25 |
Sale |
13.42 |
2,336 |
31,349 |
122,505 |
| Sweeny Nicole | Chief Commercial Officer |
Aug 22 '25 |
Sale |
13.22 |
1,864 |
24,647 |
28,771 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER |
Aug 22 '25 |
Sale |
13.22 |
2,362 |
31,232 |
130,881 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER |
Aug 22 '25 |
Sale |
13.22 |
10,940 |
144,657 |
386,858 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER |
Aug 22 '25 |
Sale |
13.22 |
2,942 |
38,901 |
119,841 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER |
Aug 18 '25 |
Sale |
13.19 |
2,649 |
34,932 |
129,493 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER |
Aug 18 '25 |
Sale |
13.19 |
2,939 |
38,757 |
116,533 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
13.19 |
4,409 |
58,141 |
374,548 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER |
Jul 09 '25 |
Sale |
15.69 |
32,979 |
517,523 |
369,595 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):